9 medicines held by Incyte Biosciences Distribution B.V. on the Irish market, from the HPRA register of authorised products.
| Medicine | Active substance | Licence holder | Status |
|---|---|---|---|
| Iclusig 15 mg film-coated tablets EU/1/13/839/001-002 |
Ponatinib hci | Incyte Biosciences Distribution B.V. | — |
| Iclusig 30 mg film-coated tablets EU/1/13/839/006 |
Ponatinib hci | Incyte Biosciences Distribution B.V. | — |
| Iclusig 45 mg film-coated tablets EU/1/13/839/003-004 |
Ponatinib hci | Incyte Biosciences Distribution B.V. | — |
| MINJUVI 200 mg powder for concentrate for solution for infusion EU/1/21/1570/001 |
Tafasitamab | Incyte Biosciences Distribution B.V. | — |
| Opzelura 15 mg/g Cream EU/1/23/1726/001 |
Ruxolitinib | Incyte Biosciences Distribution B.V. | — |
| Pemazyre 13.5 mg tablets EU/1/21/1535/005-006 |
Pemigatinib | Incyte Biosciences Distribution B.V. | — |
| Pemazyre 4.5 mg tablets EU/1/21/1535/001-002 |
Pemigatinib | Incyte Biosciences Distribution B.V. | — |
| Pemazyre 9 mg tablets EU/1/21/1535/003-004 |
Pemigatinib | Incyte Biosciences Distribution B.V. | — |
| Zynyz EU/1/24/1800/001 |
Retifanlimab | Incyte Biosciences Distribution B.V. | — |
Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 6 July 2026).
Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.